Levetiracetam Sun

Levetiracetam, the active ingredient in Levetiracetam Sun, is an antiepileptic presented as an oral dosage form for oral use. It is indicated for the treatment of partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients requiring seizure control.

GNH USA supplies Levetiracetam Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is used to manage epileptic disorders by stabilising neuronal activity.

- Partial‑onset seizures: reduces seizure frequency in focal epilepsy patients. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes across the brain. - Myoclonic seizures: diminishes rapid muscle jerks associated with certain epilepsy syndromes.

Levetiracetam may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or low in energy. - Somnolence: increased sleepiness during the day. - Headache: mild to moderate cranial pain. - Irritability: mood changes or increased agitation. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal thoughts: emergence of depressive ideation or self‑harm urges. - Mood disorders: significant depression or aggression. - Blood dyscrasias: rare cases of leukopenia or thrombocytopenia. - Multi‑organ hypersensitivity: systemic allergic response involving liver or kidneys.

Before initiating therapy, clinicians should consider several safety factors.

- Renal impairment: assess kidney function and adjust dose if necessary. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Pregnancy: risk category unknown; discuss potential benefits and risks with the patient. - Concomitant CNS depressants: observe for enhanced sedation or respiratory depression. - Psychiatric symptoms: watch for new or worsening mood changes, depression, or aggression. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenobarbital: can reduce levetiracetam levels, diminishing seizure control. - Phenytoin: may decrease levetiracetam exposure, requiring close monitoring.

Moderate Interactions (Monitor Closely): - Alcohol: additive CNS depression may increase drowsiness. - Other antiepileptics: combined therapy may necessitate dose adjustments. - Renal excretion inhibitors: monitor renal function and levetiracetam levels.